Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial

被引：0
作者：
Rajesh Sinha
Vishal Jhanji
Kamna Verma
Namrata Sharma
Nihar R. Biswas
Rasik B. Vajpayee
机构：
[1] All India Institute of Medical Sciences,Rajendra Prasad Centre for Ophthalmic Sciences
[2] University of Melbourne,Centre for Eye Research Australia
[3] Royal Victorian Eye and Ear Hospital,Department of Ophthalmology and Visual Sciences
[4] The Chinese University of Hong Kong,Ocular Pharmacology, Rajendra Prasad Centre for Ophthalmic Sciences
[5] All India Institute of Medical Sciences,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2010年 / 248卷
关键词：
Keratoplasty; Cyclosporine; Corneal graft rejection; High-risk keratoplasty;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1167 / 1172
页数：5
相关论文
共 42 条
[41]   Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial [J].
Rao, A. Tarakeswara ;
Gupta, Amit ;
Chauhan, Tulika ;
Basu, Sayan ;
Batra, Nitin ;
Sharma, Namrata ;
Sangwan, Virender S. ;
Gupta, Vinay ;
Mukherjee, Shoibal .
BMC OPHTHALMOLOGY, 2023, 23 (01)
[42]   Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial [J].
A Tarakeswara Rao ;
Amit Gupta ;
Tulika Chauhan ;
Sayan Basu ;
Nitin Batra ;
Namrata Sharma ;
Virender S Sangwan ;
Vinay Gupta ;
Shoibal Mukherjee .
BMC Ophthalmology, 23
12345